SIXTH AMENDMENT TO LEASELease • August 8th, 2018 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances)
THIS SIXTH AMENDMENT TO LEASE (this “Sixth Amendment”) is entered into as of May 11, 2018 (the “Effective Date”), by and between POINT RICHMOND R&D ASSOCIATES II, LLC, a California limited liability company (“Landlord”), and SANGAMO THERAPEUTICS, INC., a Delaware corporation (formerly known as Sangamo Biosciences, Inc., a Delaware corporation) (“Tenant”), with reference to the following facts:
